McKinsey Exec On Generative AI in R&D And Pharmacovigilance, Digital Twins

 
• By Anju Ghangurde

McKinsey & Company's senior partner Vikas Bhadoria, in this first instalment of a wide-ranging two-part interview with Scrip, outlines a number of use cases to define where pharma currently is and the potential value that can be unlocked as industry adopts new technologies such as generative AI, digital twins and the metaverse.

Pharma Could Realize Significant Value From New Technologies • Source: Shutterstock

More from Business

More from Scrip